Australian Natural Therapeutics Group (ANTG) has appointed David Wragg as its partnerships and distribution manager, in a newly created role.
Wragg joined from Cannatrek, where he was general manager.
ANTG founder and chief executive Matt Cantelo said: “We are thrilled to welcome David to the ANTG family.
“His industry insight and ability to build meaningful, purpose-driven relationships will be instrumental in delivering value to patients, prescribers and our partners.”
Bioxyne
Bioxyne has filed a summons in the NSW Supreme Court against major shareholder Ian Owles alleging he made misrepresentations resulting in shares being issued to him.
Owles became a significant shareholder in Bioxyne, holding around 6.1%, in May 2023.
Bioxyne told the ASX: “The claim seeks relief pursuant to sections 236 and 237 of the Australian Consumer Law (NSW) arising from misrepresentations made by Mr Owles which led to the issue of shares to him in Bioxyne.”
The company is claiming relief for loss and damage, or alternatively that the shares issued to Owles be declared void from the outset, or that he not be entitled to enforce his rights in respect of the shares.
Bioxyne said the summons has “no impact” on its successful operations. No further details were given.
Epsilon Healthcare
Epsilon Healthcare has appointed chief financial officer Daniel Kaplon as its new company secretary, replacing Richard Legge who held the position for 12 months.
Kaplon is a chartered accountant with more than 25 years’ experience in finance, operations, and commercial leadership roles across ASX-listed and private companies in healthcare, health technology, and manufacturing.
Epsilon CEO and managing director Peter Giannopoulos said: “Daniel brings a wealth of experience having worked across numerous listed companies, and we are confident that his expertise will be a tremendous asset to the company as we continue our relaunch and growth strategies.”
The Epsilon board thanked Legge for his contributions as company secretary and wished him “every success in his future professional endeavours”.